PA
BRSP

PharVision Advisers’s BrightSpire Capital BRSP Stock Holding History

PharVision Advisers’s Portfolio BRSP Stock Details BRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81K Buy
+14,857
New +$85.2K 1.53% 34

Other funds holding BRSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WAM
Waterfall Asset Management New York $163M AUM 0.31% 1-Year Est. Return

PharVision Advisers's BRSP Position: Q2 2026 in Review

PharVision Advisers opened a new position in BrightSpire Capital (BRSP) in Q2 2026: 14,857 shares worth $81K. The stake represents 1.53% of the portfolio and ranks #34 among its holdings.

229 funds tracked by Wall St. Rank hold BRSP as of Q2 2026.

  • PharVision Advisers held 14,857 shares of BrightSpire Capital worth $81K as of Q2 2026.
  • BrightSpire Capital was a new PharVision Advisers position in Q2 2026.
  • BrightSpire Capital made up 1.53% of PharVision Advisers's portfolio in Q2 2026, its #34 holding.
  • 229 funds tracked by Wall St. Rank held BrightSpire Capital as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.